Literature DB >> 8142919

Anti-tumorigenic chalcones.

S Shibata1.   

Abstract

On the basis of our recent findings that licochalcone A isolated from Xin-jiang licorice showed anti-inflammatory and anti-tumorigenic activities, we synthesized more than 40 chalcone derivatives to examine their anti-tumorigenic activities. In vitro inhibitory activity against phosphorylation of phospholipids promoted by tetradecanoylphorbol-13-acetate (TPA) in HeLa cells was adopted as a screening test for anti-tumor-promoting effect. In vivo experimental mouse skin tumors initiated by dimethylbenz[a]-anthracene (DMBA) and promoted by TPA were used to test the anti-tumor-promoting effect of chalcones. In the results, 3'- and 4'-methyl-3-hydroxychalcone showed the highest potency in inhibiting tumorigenesis. They also showed a remarkable inhibitory effect on the proliferation of HGC-27 cells derived from human gastric cancer. We discuss the structure-activity relationship, including stereo-chemical phototransformation, of some chalcone derivatives with reference to their ultraviolet (UV) and nuclear magnetic resonance (NMR) spectroscopic data.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8142919     DOI: 10.1002/stem.5530120109

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  12 in total

1.  The winding road of the uvaretin class of natural products: from total synthesis to bioactive agent discovery.

Authors:  Johnathan Dallman; Ashabha Lansakara; Thi Nguyen; Chamitha Weeramange; Wasundara Hulangamuwa; Ryan J Rafferty
Journal:  Medchemcomm       Date:  2019-06-11       Impact factor: 3.597

2.  Novel chalcone derivatives as potent Nrf2 activators in mice and human lung epithelial cells.

Authors:  Vineet Kumar; Sarvesh Kumar; Mohammad Hassan; Hailong Wu; Rajesh K Thimmulappa; Amit Kumar; Sunil K Sharma; Virinder S Parmar; Shyam Biswal; Sanjay V Malhotra
Journal:  J Med Chem       Date:  2011-05-19       Impact factor: 7.446

Review 3.  Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases.

Authors:  Mariola J Edelmann; Benjamin Nicholson; Benedikt M Kessler
Journal:  Expert Rev Mol Med       Date:  2011-11-17       Impact factor: 5.600

4.  (E)-1-(Pyridin-2-yl)-3-(3,4,5-trimeth-oxy-phen-yl)prop-2-en-1-one.

Authors:  Hoong-Kun Fun; Thitipone Suwunwong; Suchada Chantrapromma
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-08-27

5.  (E)-1-(2-Amino-phen-yl)-3-(3,4,5-trimeth-oxy-phen-yl)prop-2-en-1-one.

Authors:  Suchada Chantrapromma; Pumsak Ruanwas; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-08-27

6.  (E)-2-[4-(Trifluoro-meth-yl)benzyl-idene]-2,3-dihydro-1H-inden-1-one.

Authors:  Ang Chee Wei; Mohamed Ashraf Ali; Tan Soo Choon; Ibrahim Abdul Razak; Suhana Arshad
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-01-31

7.  Cytotoxicity of selected novel chalcone derivatives on human breast, lung and hepatic carcinoma cell lines.

Authors:  Maryam Nakhjavani; Afshin Zarghi; Farshad H Shirazi
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

8.  (E)-1-Phenyl-3-[4-(trifluoro-meth-yl)phen-yl]prop-2-en-1-one.

Authors:  Pei-Hua Zhao; Er-Jun Hao; Ya-Qing Liu; Gui-Zhe Zhao
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-08-23

9.  The flavokawains: uprising medicinal chalcones.

Authors:  Nadiah Abu; Wan Yong Ho; Swee Keong Yeap; M Nadeem Akhtar; Mohd Puad Abdullah; Abdul Rahman Omar; Noorjahan Banu Alitheen
Journal:  Cancer Cell Int       Date:  2013-10-22       Impact factor: 5.722

10.  Simple Syntheses of Two New Benzo-Fused Macrocycles Incorporating Chalcone Moiety.

Authors:  Rina Mondal; Swati Samanta; Saheli Sarkar; Asok K Mallik
Journal:  Int Sch Res Notices       Date:  2014-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.